Federal Reserve Governor Waller said Tuesday's CPI and incoming data will determine policy direction, warning that if inflation remains well above the 2% target the Fed may need to raise rates in the short term. He described policy as at a crossroads and expressed concern recent reports show price pressures broadening beyond tariffs and energy — potentially signaling more entrenched, systemic inflation that would require tighter policy. If core CPI prints hot again this week, the FOMC would have

Korean media reported AmCham Korea has launched the "K-Doorknock" program to promote Korean companies' expansion into the U.S.; the initial delegation includes Hyundai Motor Group and LG Group.

China's State Council issued the National Health 15th Five-Year Plan, committing full-chain support for innovative drugs and medical devices. It directs regulators to optimize review and approval of innovative and clinically urgent medicines and to establish a comprehensive clinical evaluation system to support clinical use. The plan calls for accelerated R&D and application of cell and gene therapies, next‑generation antibodies, new vaccines, nucleic‑acid drugs and radiopharmaceuticals, and for strengthened emergency vaccine and drug R&D, production and deployment. It seeks to expand pediatric drug options, deepen medtech–clinical collaboration and boost R&D of core technologies, components and finished high‑end devices. The plan also promotes AI across the pharma and medtech value chain and instructs improvement of health‑insurance support mechanisms, including refinement of the innovative‑drug reimbursement/catalogue.